Member Info for WeTookPelham

Scancell's fierce but bizarre determination to stay firmly under the radar with it's news announcements does the SP no favours at all (in the short term).

P.s. Do we know if Ichor have finished their transactions?

CW I assume you mean "not" going to take long?

The spider web of connections seem to link everywhere.

Merck will be quite miffed you'd think?

I don't know why sclp can't just summarise all of their rns titles more obviously? I.e.

https://www.investegate.co.uk/getbusy-plc--getb-/rns/no-exposure-from-silicon-valley-bank-situation/202303130700087200S/

Yeah, funny that.

RR why don't you give your favourite obsession inan the right to reply over in the other board to your point?

But all price predictions without some kind backing up is idiotic.

Hopefully they know an additional source of income is coming forthwith, hence the quiet(?) confidence.

Totally forgot, the "Crackhead inverse indicator (TM)" should mean we go bullish soon enough. Thanks for heads up.

Hey crackhead, I have you filtered so I don't have read your bile. Remember when you predicted 5p and got that so catastrophically wrong. You must be feeling like such a complete idiot still?

As mentioned previously I do think Merck with what they said about actively acquiring smaller bio's (as proved by the opko deal) will, IMO, be looking at Scancell, especially if Pfizer steal Seagen from under their noses.

...of RNS title wording, I don't think the SP would be where it is this morning if the company decided to accurately state what they actually thought.

Hi TF, also see cleaner world's post "Type Modi into McMillan"

It definitely is worth doing just this, great insight,band yes progress afoot.

Nice spot CW.

Sentiment matters IMO. The wider market you'd think would have paid more attention initially with "very", again IMO.

Also a consistent message matters also.

https://www.scancell.co.uk/careers

@chester18, exactly the point konarA and myself were making. Why the inconsistency? They've clearly downplayed the RNS, IMO.

"Underpromise and overdeliver is the right balance to strike (especially, I should point out, with a known seller poised with their finger over the sell button!)"

There's under promising and then there's under promising...IMO they take it too far, if you have something to shout about, shout about it IMO.

konarA, another very good point, I was wondering the same, why did they not see it fit to put "very" in the RNS title when clearly they do think it is "very" encouraging? Deliberate downplay? This along with the IMO confusing/vague explanation of the 8 week results does make me wonder if they don't want broader market to pick up on these results?

Didn't someone mention that on LinkedIn they were also posting the "very encouraging" header on their re-posts?

My stance is mostly that of being bored of waiting.